AMAG Pharmaceuticals Announces Divestiture of Cord Blood Registry®
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/13/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Janney Montgomery Scott Downgrades AMAG Pharmaceuticals (AMAG) to Neutral
June 15, 2018 10:32 AM EDTJanney Montgomery Scott downgraded AMAG Pharmaceuticals (NASDAQ: AMAG) from Buy to Neutral.
For an analyst ratings summary and ratings history on AMAG Pharmaceuticals click here. For more ratings news on AMAG Pharmaceuticals click here.
Shares of AMAG Pharmaceuticals closed at $24.75 yesterday.
... MoreAMAG Pharma (AMAG) to Resume Trading at 7:30 am ET
June 15, 2018 7:25 AM EDTAMAG Pharma (NASDAQ: AMAG) to Resume Trading at 7:30 am ET
... More